Advanced search
Advanced search
Advanced search
Advanced search
Advanced search
Komitet Biotechnologii PAN ; Instytut Chemii Bioorganicznej PAN
The market of medicines in new members of European Union with population of 75 million people totaled in € 7 billions. The product patents were implemented during 1990’s in these countries. Patent protection is a key concern for research - based industry in unified market. In central and Eastern European markets the generics make about 70% of all medicines prescribed. The novelty on the market are “authorized generics”.
Biotechnologia, vol.76, 1 (2007)-.
0860-7796 ; oai:rcin.org.pl:87166 ; IChB B-72
Biblioteka Instytutu Chemii Bioorganicznej PAN
Licencja Creative Commons Uznanie autorstwa-Na tych samych warunkach 4.0
Instytut Chemii Bioorganiczneji Polskiej Akademii Nauk
Instytut Chemii Bioorganiczneji Polskiej Akademii Nauk
Oct 2, 2020
Dec 6, 2019
298
https://rcin.org.pl./publication/113567
Edition name | Date |
---|---|
The pharmaceutical industry, innovation, generics and competitiveness in the context of EU Enlargement | Oct 2, 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Nowak, Jacek K.
Twardowska, Aleksandra Witek, Rafał
Pozorska-Twardowska, Aleksandra Twardowski, Tomasz
Janik-Janiec, Barbara Twardowska, Aleksandra Twardowski, Tomasz